Stone Ridge Asset Management’s Lifecore Biomedical LFCR Stock Holding History

Stone Ridge Asset Management’s Portfolio LFCR Stock Details LFCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-10,240	Closed	-$121K	–	1186
2018 Q4	$121K	Sell	10,240 -600	-6%	-$8.24K	0.01%	1182
2018 Q3	$156K	Sell	10,840 -19,929	-65%	-$276K	0.01%	1213
2018 Q2	$458K	Hold	30,769	–	–	0.03%	831
2018 Q1	$402K	Sell	30,769 -1,400	-4%	-$18.4K	0.02%	894
2017 Q4	$405K	Buy	+32,169	New	+$407K	0.03%	917

Other funds holding LFCR

NIMC

NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return

Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Walthausen & Co Malta, New York $120M AUM 2.66% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

ICOM

Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return

Stone Ridge Asset Management's LFCR Position: Q1 2019 in Review

Stone Ridge Asset Management sold out of Lifecore Biomedical (LFCR) in Q1 2019, closing a stake of 10,240 shares — an estimated $121K sold.

Stone Ridge Asset Management first reported a position in LFCR in Q4 2017 and held it in 5 quarters. The position peaked at $458K in Q2 2018. 91 funds tracked by Wall St. Rank hold LFCR as of Q1 2019.

Stone Ridge Asset Management reported no remaining Lifecore Biomedical position as of Q1 2019 after selling out during the quarter.
Stone Ridge Asset Management sold 10,240 Lifecore Biomedical shares in Q1 2019, an estimated $121K.
Stone Ridge Asset Management first reported a position in Lifecore Biomedical in Q4 2017 and held it in 5 quarters.
Stone Ridge Asset Management's Lifecore Biomedical position peaked at $458K in Q2 2018.
91 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q1 2019.

Based on Stone Ridge Asset Management's 13F filing for Q1 2019, filed 14 May 2019.